Efforts to further increase commercial readiness ongoing as Phase 3 PATHFNDR trials of paltusotine in acromegaly approach topline data readouts which are expected in 2H 2023 Phase 2 trial of paltusotine in carcinoid syndrome on track for topline data in 2H 2023 Clinical trials of CRN04894 in ACTH-dependent Cushing's Syndrome and Congenital Adrenal Hyperplasia expected to begin in 1Q 2023 SAN DIEGO, Jan.  09, 2023  (GLOBE NEWSWIRE) -- Crinetics P…

Benzinga

New York

United States

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference - Crinetics Pharmaceuticals (NASDAQ:CRNX)

Ad Fontes Media

Media Bias/Fact Check

bluebird bio, Inc. (Nasdaq: BLUE) (the Company) today announced updates to be presented at the 41st Annual J.P. Morgan Healthcare conference including

Business Wire

Howard Buffett

Crystal River

Citrus County

Florida

bluebird bio Provides Update on Commercial Launch Progress, Program Milestones and 2023 Financial Outlook Ahead of Company Presentation at 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will present an update on its commercial progress and R&D pipeline at the 41st Annual J.P. Morgan...

PR Newswire

Cision

PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference

Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) 41st Annual J.P.

Seeking Alpha

Vertex Pharmaceuticals Incorporated (VRTX) 41st Annual J.P. Morgan Healthcare Conference - (Transcript)

–   On track to fulfill all elements of Vision 3x3 to build a sustainable, profitable, leading biopharma company  COPENHAGEN, Denmark, Jan.  08, 2023 ...

Globe Newswire

Apollo Global Management

Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference

PHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC) announced that Lalo Flores, Ph.D., Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, …

MyChesCo

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Real-Time News, Market Data, and Stock Quotes for Healthcare Stocks @ healthstockshub.com

healthstockshub.com

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 41st Annual J.P. Morgan Healthcare Conference Call January 9, 2023 11:15 AM ET Company Participants Reshma Kewalramani - Chief Executive Officer and President Charlie Wagner - Chief Financial Officer Stuart Arbuckle - Chief Operating Officer David Altshuler - Executive Vice President, Global Research, and Chief Scientific Officer

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference - Crinetics Pharmaceuticals (NASDAQ:CRNX)

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics